RotaTeq (Live attenuated pentavalent Rotavirus oral vaccine) / Merck (MSD)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RotaTeq (Live attenuated pentavalent Rotavirus oral vaccine) / Merck (MSD)
2014-004252-60: Shedding and immune response of rotavirus vaccine (RotaTeq) Rotavirusrokotteen (RotaTeq) erittyminen ja immuunivaste

Ongoing
4
250
Europe
RotaTeq, RotaTeq
Vaccine Research Center, University of Tampere, Vaccine Research Center, University of Tampere
Test subjects are healthy. Tutkittavat ovat terveitä.
 
 
2019-001986-34: Maternal pertussis Immunization in FInland Study - MIFI Study

Not yet recruiting
4
160
Europe
Boostrix, Infanrix hexa, RotaTeq, Synflorix, Suspension for injection in pre-filled syringe, Powder and suspension for suspension for injection, Oral solution, Boostrix, Infanrix hexa, RotaTeq, Synflorix
Turku University Hospital, The Foundation for Paediatric Research
Pertussis Infection, Whooping Cough, Body processes [G] - Immune system processes [G12]
 
 

Download Options